Biosimilar 17+
An FDA Purple Book Compendium
Dabbling Badger LLC
Designed for iPad
-
- USD 1.99
Screenshots
Description
Biologic drugs offer important treatment options for patients suffering from auto-immune disorders such as rheumatoid arthritis and for common cancers including breast and colon. Biosimilar and interchangeable products, which can loosely be thought of as ‘generic’ biologics, are important for promoting competition and driving down costs. The FDA maintains a list of approved biosimilars in the Purple Book. The Biosimilar iOS app provides a handy reference to the Purple Book as well as important information related to prescribing and dispensing for clinicians and pharmacists navigating this complex area of drug therapeutics.
** Disclaimer ** - non-medical users should ask for a doctor’s advice in addition to using this app and before making any medical decisions.
What’s New
Version 1.0.5
* Fixed a bug from changes to FDA data files where all drug products were showing up as discontinued.
App Privacy
The developer, Dabbling Badger LLC, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Not Collected
The developer does not collect any data from this app.
Privacy practices may vary based on, for example, the features you use or your age. Learn More
Information
- Seller
- Dabbling Badger LLC
- Size
- 1.6 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 16.0 or later.
- iPad
- Requires iPadOS 16.0 or later.
- Mac
- Requires macOS 13.0 or later and a Mac with Apple M1 chip or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English
- Age Rating
- 17+ Frequent/Intense Medical/Treatment Information
- Copyright
- © 2023 Dabbling Badger LLC
- Price
- USD 1.99
Supports
-
Family Sharing
Up to six family members can use this app with Family Sharing enabled.